M&A Deal Summary |
|
---|---|
Date | 2019-09-16 |
Target | Savant HWP - 18-MC Drug |
Sector | Life Science |
Buyer(s) | MindMed |
Sellers(s) | Savant HWP |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic-inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. MindMed is based in New York, New York.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Nevada) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2019) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-02-26 |
HealthMode
San Francisco, California, United States HealthMode is a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring. HealthMode was founded in 2017 and is based in San Francisco, California. |
Buy | - |
Savant HWP, Inc. develops pharmaceutical products that improve health, maintain wellness and prevent disease. Savant HWP, Inc. identify undervalued opportunities to create innovative products in areas where work has the greatest impact, including addiction medicine and neglected disease like leishmaniasis.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Nevada) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2019) | 1 of 1 |